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ABSTRACT
Background: Systemic lupus erythematosus (SLE) is a multisystem disease caused by
production and deposition of imn:une-conrpiex resulting in tissue dan.rage. Subacute cutaneons
lupus ery'thematosus (SCLE) is part of cutaneus lupus ery.thematosus. Morphea (localized
sclerodema) is a fibrosing clisorder of the skin and subcutaneous tissues. Systemic lupus
er1'thematosus with SCLE type and morphea in the same patient is a rare case and the incidence
retnains unknown, but there were six cases have been reported. Defect of apoptosis regulation
suggested play a role in both of these autoimmune diseases.
Case report: Reporled a case of SLE with SCLE type and morphea in a 17-year-old {'emale.
There was history of hard palpable red-brownish patches on both of cheeks, right nasolabial tbld.
under both eyes, both legs, both antts, back, and scalp since Tmonths ago. Patient easily feeis
tired, complaining of joint pain, hair easy to tbll, fever, decreased of body weight. Physical
examination: hair pull test (+). There were hard palpabie atrophic scars, hyperpigmentation
plaques. atrophy lesions with various colors (white, brown, black,and violaceus).
hyperpigmentation and erfhematous macules, erythematous plaques with atrophic scars in the
centre rvith erfhematous edge. yellowish-brown scaies. Mild anemia, leukopenia, and anti-
dsDNA (+) lbund in this patient. Initially patient was diagnosed by morphea. but new lesions still
appeared. Histopathological exardnation was pertbnned and the result was SCLE. Patient
matched 4 of the I I criterias of the American Colleague of Rheumatoiogy (ACR) and diagnosecl
by SLE.
Iliscussion: Morphea ancl SCLE are skin diseases witli difl'erent clinical and pathological
appearance. The reiationship bet'il'een the two diseases has been widely debated for decades. and
has conducted research to fincl the relationship between the two diseases.
Conclusion: Working diagnosis in this patient was SLE with SCLEtype and morphea. These
three cases can occlrr at the same time. This case is still under fbllorv up.
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INTRODT]CTION
Systentic lupus erfhematosus (SLE) is a rnultisystem disease caused by the production
of antibodies and immune cornplex deposition resr"rlting in tissue damage. Lupus erythematosus
(LE) is a term for various diseases associated rvitir autoimnrrinity in nucleosome molecules and
ribonucleoprotein. Cutaneous LE (CLE) is the name for the three main categories of LE-
cutaneous: acute cutaneous LE (ACLE), subacute cutaneus LE (SCLE), and chronic cutaneus LE
(CCLE). SCLE lesions is fonned as er1'then:a and hyperpigmentation with its center Ibnled of
scar atrophy and hypopigmentation.r'l Morphea known as local scleroderma fibrosis is a disorder
of the skin and subcutaneous tissue. Morphea distinguished from systemic scierosis (sclerodenna)
by their sclerodactyly, Raynaud's phenomenon, and the change-nail fold capillaries.
Etiopathogenesis still ttnknown, bnt suspected many factors, such as trauma, toxins, some
1.
nredications. Laboratoriurn commonly fbund ANA test (+) in 460/o of cases.3Systernic lupus
erythernatosns with SCLE type and rnorphea in the same patient is a rare case and the incidence
rernains unknown. this is the seventh cases that have been repofied since last l0 years.
CASE REPORT
Reportecl a rare case morphea with SLE, SCLE type in a same woman, 17 yearsold.
Anamnesis of these patients appear brownish recl spots on both cheeks, nasolabial fbld, under the
eyes. both forearms, back, scalp expanded since 7 months ago. The history of exposure to the sun
without protection, the patient easily tired since eight months ago. joint pain, while in the physical
examination found Body Mass Index 18,36 (underweight) with hair pull test (+). Derrnatological
status: hard paipable atrophic scars, hyperpigmentation plaques, atrophy lesions with various
colors (white. brown. black. ancl violaceus), hype4rigmentation and erythematous rnacules.
erythematous piaques with atrophic soars in the centre with erythematous edge, yellowish-brown
scales. Normal mucolrs merrbrane. Laboratorium Hb 10,6 mgldl, leucocle 4.7001nm3. Patient
had 4 of the 1l criteria of ACR, photosensitivity, arthritis, hematological disorder (nTilcl anemia
and leucocfopenia). and positive anti nuclear-antibodies (ANA). We found squamous stratitjed
epithelium, partly atrophy, most hyperplasia (acanthosis) witir hyperkeratosis and llat 'rete ridges',
vacuol epithelial in epidermis and in dermis we fbund iuild-moderate lprphocy,tes and PMN
infiltration. Histopathologic changes in SCLE especially dermatitis lesions with poor-cell
interface. Working diagnosis in this patient was SLE with SCLE and ruorphea.
DISCUSSION
Morphea has diftbrent lesions with cutaneous lesions of lupus in some reported cases. In
two cases, patients suffering from SLE and also linear morphea face 4.5 years aller the diagnosis
of SLE.Whilethe twt'r other cases, patients with morphea who later complained ofjoint pain, tnalar
rash and laboratorytests lead to SLE The fifth case in patients with rnorphea 8 years, without any
other complaint is tbund coexistence u,ith SLE. Whereas in the case of sixth obtained coexistence
DLE and SLEin tire same lesion.6 Laboratory findings in SLE is a high titer ANA and anti-
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dsDNA. ANA titer can occur with lorv/normal in 30-40 percent of patients u,ith DLE; However.
less than 5 percent had a high value of ANAwhich are characteristic of SLE patients (>l:320) but
this is not spesific tbr SLE and can be tbund in other autoimune disease. 1.4 In this patient, we
fbund high ANA titer. American College of Rheumatology criteria lbr SLE is malar rash, discoid
Iesions. photosensitivity, oral ulcers. arthritis, serositis, kidney disorders. neurological disorders,
hernatoiogical disorders. imrnunological disorders, and anti-mrclear antibodies (ANA). 1,5 In this
patient we fotrnd 4 florn 1 1 criterias.
Patients with systemic lupus erythematosus who also rnorphea in the same patient is
seldom reported in the incident are still unknown. Lesions develop within a fbw rnonths of
widening the r"rpper right arm with histopathologic r-'xamination support to rnorphea overlap DLE,
laboratory tests support towards SLE. Second histopathological examination was performed and
the result was SCLE. Lir:nphohistiocytic cellular infiltrate reiatively rare. Rarely seen thickening
of the basement meubrane areai follicr.rlar plugging, or changes in epiderrnal thickness, ancl
sometimes epidermal atrophy. Infiltrating cells ollen iooked quite solicl and typically extends into
the deeper dermis (reticular) and/ or snbcutaneous, which may help to distinguish it from ACLE
or SCLE.1,5 In this patient we lbund histopathologic epidermal atrophy and mild-moderate
lynphocles ald PMN inliltration.
CONCLUSION
Morphea and SCLE are skin diseases with clifferent clinical and pathological appeararrce.
These cases can occur at the same tirne. The relationship between the two cliseases has been
widely debated fbr decades and has conducted research to find the relationship between the two
disease.
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